Liver News and Research

RSS

Caspase levels associated with liver injury

Caspase activity in the sera of patients with chronic hepatitis C infection (HCV) may be a more sensitive measure of liver injury than conventional surrogate markers like aminotransferases, according to a new study published in the November 2004 issue of Hepatology.

8 Nov 2004

Prevalence of occult HBV in hemodialysis patients is 4 to 5 times higher than standard HBsAg testing would suggest

Some kidney dialysis patients contract hepatitis B virus (HBV) during the course of their treatment, possibly from other members of the dialysis population with occult HBV.

8 Nov 2004

Britain should adopt universal hepatitis B immunisation

The United Kingdom is one of the few developed countries that have not implemented universal immunisation. Because the burden of hepatitis B was low and individual rights were considered paramount, a policy of selective immunisation of high-risk groups, such as health care workers, homosexual men, and drug addicts, has been followed.

5 Nov 2004

British Medical Association calls on Health Secretary to deliver tough action to protect the nation's health

The British Medical Association today (4 November 2004) calls on Health Secretary John Reid to deliver tough action to protect the nation's health, as he finalises the White Paper on Public Health for England.

4 Nov 2004

Health professionals fall short for Hepatitis C patients

People living with Hepatitis C are highly critical of the treatment they have received from health professionals, particularly doctors, according to a new study by a University of Auckland sociology researcher.

3 Nov 2004

Maxim Pharmaceuticals to withdraw NDA for advanced malignant melanoma

Maxim Pharmaceuticals has announced that based upon the negative outcome of it's confirmatory Phase 3 clinical trial (M0104) studying Ceplene(TM) (histamine dihydrochloride) in combination with Interleukin-2 (IL-2) in advanced malignant melanoma patients with liver metastases, it plans to close the treatment protocol approved by the FDA earlier this year.

2 Nov 2004

Clinical trial of investigational oxygen-carrying blood substitute for use at the scene of injury

Loyola University Health System begins today the national clinical trial using PolyHeme®, an investigational oxygen-carrying blood substitute designed to increase survival of critically injured and bleeding trauma patients at the scene of injury.

1 Nov 2004

Program triples hepatitis B vaccination rates in targeted regions of rural China

The Bristol-Myers Squibb Foundation and the China Foundation for Hepatitis Prevention and Control (CFHPC) announced the results of a collaborative grassroots education and vaccination program designed to fight the spread of one of China's most pressing health problems -- hepatitis B.

1 Nov 2004

New approaches for the treatment of chronic hepatitis C

Data from two ongoing studies testing new approaches for the treatment of chronic hepatitis C was presented at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) this afternoon.

1 Nov 2004

First home-testing device for phenylketonuria (PKU) patients

Home-testing kits have made it easier for diabetics and hypertension patients to track their conditions, but such self-monitoring hasn’t been possible for people with phenylketonuria (PKU).

1 Nov 2004

Discovery of a number of potent and selective small molecule inhibitors of the hepatitis C (HCV) NS3/4 protease

InterMune announced today the presentation of preclinical data on the discovery and characterization of a number of potent and selective small molecule inhibitors of the hepatitis C (HCV) NS3/4 protease.

1 Nov 2004

More to MRSA infection than just exposure to antibiotics

Johns Hopkins researchers report potentially life-threatening hospital infections with bacteria resistant to the antibiotic methicillin can occur even if patients havent been treated with that drug.

1 Nov 2004

Pegasys with ribavirin combo may best for reducing hepatitis C viral levels

Interim study results indicate a certain drug combination treatment may suppress the hepatitis C virus more quickly than another.

1 Nov 2004

Red wine delivered though an aerosol for COPD, asthma, and possibly even arthritis

Homing in on mechanisms for the reported effectiveness of resveratrol, which is found in red wine, researchers at Imperial College London, England, confirmed its broad anti-inflammatory action, and found potential for applications in chronic obstructive pulmonary disease (COPD), asthma, and possibly even arthritis.

29 Oct 2004

Selling paracetamol and other painkillers in smaller pack sizes has slashed rates of suicide

Selling paracetamol and other painkillers in smaller pack sizes has slashed rates of suicide and damage to the liver from paracetamol poisoning, concludes a study on bmj.com this week.

29 Oct 2004

Strong-flavored onions could potentially be great for fighting cancer

Researchers at Cornell University have found, in preliminary lab studies, that members of the onion family with the strongest flavor — particularly New York Bold, Western Yellow and shallots — are the best varieties for inhibiting the growth of liver and colon cancer cells.

21 Oct 2004

Atypical antipsychotics commonly used to treat children with aggression, bipolar disorder, and schizophrenia may trigger insulin resistance

Researchers from the Johns Hopkins Children's Center say a group of drugs known as "atypical antipsychotics" that are commonly used to treat children with aggression, bipolar disorder, and schizophrenia may trigger insulin resistance, a condition that increases the risk of developing Type 2 diabetes and heart disease later in life.

21 Oct 2004

Researchers are one step closer to understanding how high carbohydrate diets lead to obesity and diabetes

Researchers at UT Southwestern Medical Center at Dallas are one step closer to understanding how high carbohydrate diets lead to obesity and diabetes.

19 Oct 2004

Tiny beads called microspheres could become the new weapon in the fight against liver cancer

The new treatment involves injecting thousands of the beads via an incision into the hepatic artery - the main blood supply for the liver. When the microspheres are injected they are picked up by the blood flow and eventually lodge in the malignant cells of the tumours.

19 Oct 2004

FDA approves partial artificial heart

The U.S Food and Drug Administration (FDA) has approved a partial artificial heart intended to keep people alive in the hospital while they are awaiting a heart transplant.

18 Oct 2004

Liver News and Research

Caspase levels associated with liver injury

Prevalence of occult HBV in hemodialysis patients is 4 to 5 times higher than standard HBsAg testing would suggest

Britain should adopt universal hepatitis B immunisation

British Medical Association calls on Health Secretary to deliver tough action to protect the nation's health

Health professionals fall short for Hepatitis C patients

Maxim Pharmaceuticals to withdraw NDA for advanced malignant melanoma

Clinical trial of investigational oxygen-carrying blood substitute for use at the scene of injury

Program triples hepatitis B vaccination rates in targeted regions of rural China

New approaches for the treatment of chronic hepatitis C

First home-testing device for phenylketonuria (PKU) patients

Discovery of a number of potent and selective small molecule inhibitors of the hepatitis C (HCV) NS3/4 protease

More to MRSA infection than just exposure to antibiotics

Pegasys with ribavirin combo may best for reducing hepatitis C viral levels

Red wine delivered though an aerosol for COPD, asthma, and possibly even arthritis

Selling paracetamol and other painkillers in smaller pack sizes has slashed rates of suicide

Strong-flavored onions could potentially be great for fighting cancer

Atypical antipsychotics commonly used to treat children with aggression, bipolar disorder, and schizophrenia may trigger insulin resistance

Researchers are one step closer to understanding how high carbohydrate diets lead to obesity and diabetes

Tiny beads called microspheres could become the new weapon in the fight against liver cancer

FDA approves partial artificial heart

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Latest News